# Exploratory Study of Anti-BCMA-CD19 CAR-T Cell Therapy in Relapsed or Refractory IgG4-Related Disease

> **NCT07148791** · PHASE2 · RECRUITING · sponsor: **Chinese PLA General Hospital** · enrollment: 9 (estimated)

## Conditions studied

- IgG4 Related Disease
- B-cell Mediated Autoimmune Disorders

## Interventions

- **BIOLOGICAL:** Anti-BCMA-CD19 CAR-T cells

## Key facts

- **NCT ID:** NCT07148791
- **Lead sponsor:** Chinese PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-05
- **Primary completion:** 2027-09-01
- **Final completion:** 2029-12-31
- **Target enrollment:** 9 (ESTIMATED)
- **Last updated:** 2025-09-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07148791

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07148791, "Exploratory Study of Anti-BCMA-CD19 CAR-T Cell Therapy in Relapsed or Refractory IgG4-Related Disease". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07148791. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*